SUMMARY Nine patients who had an eye-wall biopsy were evaluated for long-term results. The follow-up time ranged from 21/2 months to 7 years. Six patients were followed up for more than 2 years. Few operative and postoperative complications were observed. Except for 1 patient with reticulum cell sarcoma, all eyes retained preoperative visual acuity. Tractional retinal detachment occurred only in 1 patient, who had vitreous bands around the biopsy site and did not undergo a simultaneous vitrectomy during the biopsy operation.
The follow-up time ranged from 21/2 months to 7 years (Table 1 ). Six patients were followed up for more than 2 years.
Materials and methods
Between 1973 and 1980 a total of 9 patients underwent schlerochorioretinal biopsies (Table 1) . Cases 1 and 2 were done to rule out sympathetic ophthalmia. In case 7 the biopsy showed an intraocular reticulum cell All patients had complete, extensive medical and ophthalmological examinations preoperatively. The 2 patients operated on in India were given local anaesthesia; those in the United States had general anaesthesia.
SURGICAL TECHNIQUE
A 3600 peritomy was performed, and the rectus muscles were isolated with 4-0 silk sutures. A Peyman eye basket (Fig. lA) , 12 mm in diameter, was sutured to the sclera (Fig. IB ). An 8 mm trephine (Fig. IC) was used to demarcate approximately half the thickness of the sclera. The sclera was then dissected ( an area within the partially dissected 8 mm area (Fig.  IE) . After surface and penetrating diathermy (Fig.  IF) the sclera, choroid, and retina were then penetrated through the margin of the 4 mm button with a No. 52 Beaver blade. The section was completed with curved corneoscleral scissors (Fig. IG) . All patients except case 3 had a vitrectomy through the biopsy site with the vitrophage (Fig. 1H) . After vitrectomy the resected area was covered with the 8 mm partialthickness sclera; 4 interrupted sutures were applied and a 9-0 running nylon suture was added (Fig. 11) . The intraocular pressure was re-established with an injection of air through the graft edge of a 30-gauge cannula (Fig. 1J) .
Results
During the surgical procedure minor choroidal bleeding occurred in 4 patients. The choroidal bleeding originated from the biopsy site and was easily controlled with diathermy (Table 1) . Early postoperative vitreous haemorrhage that occurred in one eye cleared within 3 weeks. Also in the early postoperative period 1 patient (case 3, Table 1 ) developed thick vitreoretinal traction bands around the biopsy site that progressed to a tractional retinal detachment. This patient did not have a vitrectomy procedure during the biopsy operation. The patient's visual acuity remained unchanged, and it was thought that additional surgery to reattach the retina would not improve the vision. All patients operated on after this underwent subtotal vitrectomy through the biopsy site.
After surgery all eyes were inflamed for a period of 2 weeks. By slit-lamp examination the anterior chamber showed 2 to 3+ cells on the first postoperative day. By 1 to 2 weeks later there was only trace flare in the anterior chamber. No patient complained of pain or unusual discomfort. Within 2 weeks of surgery the ocular media were clear and a chorioretinal scar was visible (Fig. 2, top) ,------developed minimal posterior subcapsular cataract in the late postoperative period. Although small, the biopsy specimens showed intact sclera, choroid, and retina ( Fig. 2, middle) . The cellular structures were well preserved for light and electron microscopy ( Fig.   2 , bottom). 
Discussion
The retina and choroid are among the few tissues in the human body that do not undergo biopsy routinely. Although the concept of eye-wall biopsy is unthinkable in a healthy eye, with proper technique it is possible to obtain a biopsy specimen of diseased retina and choroid without significant complication.
The purpose and value of eye-wall biopsy is 2-fold. It is helpful diagnostically to identify unknown ocular diseases that may be potential threats to the visual acuity in the contralateral eye (as in our patient with suspected sympathetic ophthalmia) or even to the patient's life (as in our patient with' reticulum cell sarcoma). Eye-wall biopsy is also useful to expand future research into diseases for which uveal and retinal tissue has not been readily available for analysis with modem laboratory tests.
Encouraged by the results and few complications after extensive laboratory study, we evaluated this technique in patients with substantial retinal disease and reduced visual acuity of less than 20/200. We observed only few operative and postoperative complications. Except in 1 patient with reticulum cell sarcoma all eyes retained preoperative visual acuity. Significant complications, such as tractional retinal detachment, occurred in only 1 patient, who had vitreous tractional bands around the biopsy site. This was the only patient who did not have a vitrectomy during the biopsy procedure.
Recent studies on experimental animals by Constable and colleagues7 were also successful. In addition they reported on a short-term study in man with a follow-up period of a few days.8 Although they used a similar technique, they advocated the removal of smaller pieces of tissue (lxl 5 mm versus 4x4 mm) than we do. Constable et al., however, reported common morphologically structural changes in their biopsy specimens that we have not observed. We believe that these changes may be related to the handling of the small specimens during removal. A larger sized tissue can be better handled and can be divided in half-for example, one part for electron microscopy and the other for histochemical or biochemical study. If an infective agent is suspected, one part can be cultured for virus, bacteria, or fungus. They also suggested that a vitrectomy is unnecessary during the biopsy. We We feel that this procedure can be useful in the diagnosis of unusual ophthalmologic diseases in which the visual acuity is already compromised or the contralateral eye is in danger of being affected by a similar disease process. It may also be used when permanent visual loss is suspected from an unknown disease state and when enucleation would otherwise be recommended for diagnostic or therapeutic measurement.
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